Delivery Order SPE2DB24D2101-SPE2DB25FKMUL
- Not listed
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $4,273.95 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a $21,534 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, with a completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Botox 100 unit vials valued at $10,336.32. This firm fixed-price delivery order, with a completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. This delivery order is a child contract issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,644 to Amerisourcebergen Drug Corporation to supply 100 unit vials of BOTOX. The order is to be performed in Conshohocken, Pennsylvania from August 14 to September 5, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for BOTOX injections supports the DLA's mission to provide critical medical commodities to the armed forces....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX with a ceiling value of $230,793.30. This firm fixed-price, competitively awarded contract was executed on July 25, 2025, with an ultimate completion date of August 15, 2025. The award carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and...
- The Defense Logistics Agency awarded a $5,128.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of August 11, 2025. This is a competitively awarded, non-set-aside contract issued as a child order under a larger contract vehicle, reflecting the agency's ongoing pharmaceutical procurement needs for military and federal healthcare systems. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $110,604.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 unit vials of BOTOX. Performance will take place in Conshohocken, Pennsylvania under a September 15, 2023 end date. As a major provider of medical supplies and pharmaceuticals to the Department of Defense globally, this order for BOTOX injections supports the DLA's mission to provide critical medical commodities to military treatment facilities and beneficiaries....
- The Defense Logistics Agency awarded a $2,564.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's existing relationship with DLA for...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMULDelivery Order
The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 unit vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated its capability to meet federal procurement requirements through competitive award processes. The company serves critical federal medical procurement needs for military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This BOTOX procurement exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains through the DLA Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 7/28/25 |